Format

Send to

Choose Destination
See comment in PubMed Commons below
Nervenarzt. 2007 Mar;78(3):264, 266-8, 270-1.

[The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

[Article in German]

Author information

  • 1Abteilung für Klinische Psychiatrie und Psychotherapie, Medizinische Hochschule Hannover, Carl-Neuberg-Stasse 1, 30625 Hannover. mueller-vahl.kirsten@mh-hannover.de

Abstract

The treatment of Tourette's syndrome is a challenge. Dopamine receptor antagonists are the drugs of first choice for the treatment of tics. Because large controlled trials are lacking, there is no consensus about which of the different neuroleptic drugs should be preferred. In Germany, tiapride seems to be used most often for the treatment of tics in children - although only one small controlled trial has been performed on it till now. In adults, other dopamine receptor antagonists such as risperidone, pimozide, and sulpiride seem to be more effective than tiapride. Today it is unknown whether new atypical neuroleptic drugs including the benzamide amisulpride are more effective than the older benzamides tiapride and sulpiride.

PMID:
16924461
DOI:
10.1007/s00115-006-2131-x
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center